Agenda

Expand All +

  • October 17, 2023


  • October 18, 2023


  • October 19, 2023


  • Join us as we kick off RoboBusiness & DeviceTalks West with a welcome reception before the event starts. Fun, networking, light food & drinks will be included.

    Admission information: Claim your ticket during registration. Free to sponsors and speakers. $25 for full conference pass holders

  • The medical device industry always needs great engineers, but the career path for engineers doesn't start and end in product development. In this panel accomplished MedTech executives who began with an engineering education discuss architecting a diverse and rewarding career.
    DeviceTalks Technical Forum
    Where
    Theater

  • Smart medical implants are allowing doctors to monitor post-surgery progress with more real-time data than a single visit can provide. In an age where remote healthcare is improving access to care, new sensor technology is enabling better patient outcomes by monitoring real-time progress. In contrast to wearables, where much of the field has focused, smart medical implants can give a deeper view of biology and more actionable data. This technology is already being used in knee replacements to aid doctors in making informed care decisions during patient recovery and is poised to be incorporated into other medical implants. Canary recently introduced its first orthopedic analytic module, Canary Recovery CurvesTM. Recovery curves utilize movement data measured by Canary Medical’s proprietary implantable canturio™te tibial extension sensor technology integrated into Zimmer Biomet’s Persona IQ®. By pooling patient data, Recovery Curves provide frequent, objective aggregate population data of each patient’s activity levels and knee kinematics and ranks each patient’s knee performance versus their peers based on age group, gender and time since surgery. Clinicians can now access and use this daily functional information to determine whether to augment their in-office patient examinations and/or to update their care plans in the year following surgery. Recovery curves are the world’s first and only monitoring tool available to reproducibly characterize an individual patient’s total knee replacement recovery versus objective aggregate population data obtained from identical implantable sensors.
    DeviceTalks Technical Forum
    Where
    Room 209

  • We'll open DeviceTalks West by interviewing the leader of Abbott's Vascular business. The interview with Julie Tyler, SVP, Abbott, will explore Abbott's product platform, innovation process, and what's to come after the acquisition of Cardiovascular Systems Inc.
    Keynote
    Where
    Theater

  • Many innovations in medtech are designed to tackle challenges that occur at a specific point in treatment. While these technologies may dramatically transform outcomes for singular problems, often, patients can’t access this care, or experience other challenges following an acute event that remain unaddressed. The reality of our fractured healthcare system is that patients often encounter care that is fundamentally disconnected. Imperative Care is taking a different approach and innovating across the entire patient experience through connected innovations. By bringing together dedicated businesses – each focused on addressing a specific gap in the care continuum – the company is working to dramatically expand and improve patient care, and ultimately bring better care to more people.
    DeviceTalks
    Where
    Theater

  • Neuromodulation technologies have elicited strong expectations from investors. As products begin to close on commercial stages, companies are finding ways to work with physicians and patients to ensure these new tools can deliver. In this panel three executives from leaders in the space will share how they’re moving to build out the market for neuromodulation technologies.
    Bringing Devices to Market
    Where
    Room 210

  • The medical device is in dire need of a long-term solution for the sterilization crisis. In this panel we'll hear from Thomas Kroc, Phd, Applications Physicist III at the Fermi National Accelerator Laboratory (Fermilab) who is bringing a new approach to the challenge of making medical devices safe.
    Manufacturing & Materials
    Where
    Room 209

  • In this presentation, we'll hear how Intuitive engineers work with surgeons and care teams to understand how to make its surgical systems easier to use or, for lack of a better word, intuitive. Where should buttons go? What does the blue blinking light mean? Where should warnings be displayed for quickest access? And should surgical robotics systems across different manufacturers follow a similar template to make it easier for surgeons to master different systems?
    Engineering & Product Development
    Where
    Room 207

  • As rapid tech advancements contrast with the lengthy Verification & Validation processes in medical device verification, the MedTech and the Need for Speed panel aims to bridge this divide. Drawing from strategies in non-regulated sectors, experts will present actionable solutions to streamline updates in the MedTech realm. We'll delve into managing regulatory and cybersecurity challenges, illustrating how efficient models from other sectors can be applied to MedTech. Join us to discuss tangible approaches to optimizing updates in the regulated healthcare environment.
    DeviceTalks
    Where
    Theater

  • Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms, delivered by a wearable, portable medical device. Novocure has pioneered the use of electric fields to treat solid tumor cancers with its proprietary platform technology. Hear from Novocure’s former Chief Operating Officer and current Senior Technology Fellow, Mike Ambrogi, on Novocure’s collective drive for innovation and patient-forward approach.
    Bringing Devices to Market
    Where
    Room 210

  • In this conversation, we'll hear from advisors, experts and a medical device CFO about what it will take to build a start-up that's capable of matching and exceeding expectations. Panelists bring insights to regulatory, engineering, innovation, fund-raising, product liability issues (and why you should care) and creating real company value.
    Engineering & Product Development
    Where
    Room 207

  • To meet modern design challenges, design of delivery systems is turning from braids to laser-cut shafts. There are some time-trodden paths that are well-known, but the vast design space is surprising and offers wide ranging opportunities for performance and cost management. Settle in for an enlightening orientation to the space, guidelines, and a few pitfalls to watch out for.
    Manufacturing & Materials
    Where
    Room 209

  • The desire to make diabetes a smaller part of people’s lives has been Insulet’s passion and purpose for over 20 years. When the Omnipod 5 Automated Insulin Delivery System was cleared by the FDA in early 2022, the company knew they had achieved the remarkable -- not only in bringing the first tubeless AID system to the U.S. market, but in overcoming a number of unexpected hurdles in the development and regulatory process.Chief Technology Officer Mark Field will share Insulet’s story and explain how the company persevered to comply with various international requirements, overcome regulatory challenges, and collaborate effectively through a global pandemic to become the world’s most prescribed insulin pump, drive unprecedented growth and alter the state of the insulin pump business forever.
    Engineering & Product Development
    Where
    Room 207

  • Abbott’s MitraClip – a device that got its start in the Bay Area and is made nearby in Menlo Park – is celebrating 20 years since helping its first patient with mitral regurgitation (a leaky heart valve). Thanks to a pioneering team of researchers, scientists and doctors, MitraClip has now changed the lives of more than 200,000 people around the world. This session will cover MitraClip’s history and ongoing innovation, how the device’s design has inspired other technology, and what advances future generations of the product may hold.
    DeviceTalks
    Where
    Theater

  • Stryker neurovascular portfolio includes a range of stents, coils, and flow diversion systems has revolutionized the treatment of neurovascular conditions like cerebral aneurysms and ischemic strokes. By providing cutting-edge tools and technologies, Stryker aims to improve patient outcomes with precise and minimally invasive procedures. Continuously focusing on research and development, Stryker remains at the forefront of neurovascular innovation, transforming neurological care worldwide.
    Bringing Devices to Market
    Where
    Room 210

  • This presentation will discuss what a brain-computer interface is and the Synchron SWITCH Endovascular BCI device and how it works and helps restore digital communication for people with severe paralysis.
    Manufacturing & Materials
    Where
    Room 209

  • Join industry and clinical experts as they discuss the transformative potential of computer-based modeling and simulation in clinical trials. This session will explore how virtual human models can predict clinical outcomes, addressing current limitations in clinical development. Discover the applications of ‘In Silico’ clinical trials (ISCT) and the cutting-edge combination of AI methods with computational modeling and simulation to create entire patient cohorts, including synthetic (external) control arms. Through this strategy, the panelists will demonstrate how virtual populations can enhance the trial design and streamline the evaluation of new therapies. Additionally, the panel will discuss collaborative efforts with FDA to develop a playbook for ‘enriching’ clinical trials with frameworks to help accelerate advancements in the field. Attendees of this session will gain a comprehensive understanding of the transformative potential of computer-based modeling and simulation in predicting clinical outcomes. They will leave with insights into the latest advancements shaping the future of clinical trials while mitigating risks and costs, accelerating product approval timelines, and ultimately achieving better patient outcomes.
    DeviceTalks
    Where
    Theater

  • An update on telepresence and its adoption in MedTech across departments and functions including R&D, clinical trials, product launches and more, with discussion around how to start a telepresence program and other questions that we hear most often.
    Bringing Devices to Market
    Where
    Room 210

  • For technologies developed in university, hospital or other academic settings, it is critical to the success of both parties (sponsor institution and spin out company) that the technology be properly licensed to the company with terms that mutually align the party's interests and will be acceptable to downstream investors, partners, and/or acquirers. Join for a discussion of effective strategies for structuring and negotiating these critical agreements.
    Manufacturing & Materials
    Where
    Room 209

  • Faced with an ever-changing regulatory landscape, rapid technology innovations, and ongoing supply chain challenges, Medtech executives have never needed strategic prioritization more. However, many organizations struggle with effective prioritization. Prioritization and focus allow you to produce the significant impact your organization needs. Without strategic prioritization, dilution kills your results. In this engaging session, we will delve into prioritization, examining approaches, benefits, challenges, and the often-overlooked impact of human nature. Managers, directors, and executives should attend this session to learn: How your organization compares with other companies on strategic prioritization. The human nature factors that hamper your best efforts to focus your organization on the right things. The strategic prioritization principles that will allow you and your company to capitalize on opportunities despite your constraints and human nature inhibitors
    Engineering & Product Development
    Where
    Room 207

  • In this interview, Fred Khosravi, one of the more proficient entrepreneurs in medtech, shares Imperative Care's broad vision for helping people rebound from strokes and battle vascular disease. Imperative Care's innovation includes critical new device designs and bolder business models.
    Keynote
    Where
    Theater

  • While the buzzword is abound with several companies leading the Artificial Intelligence (AI) and Machine Learning (ML) technology trends, what is it and what is its impact in the Medical Device industry? The discipline is in its upwards trajectory of practical usage with Artificial intelligence, Machine Learning, and Robotics. This wave of change is significantly innovating the medical devices for smarter decision making, precise diagnostics and enabling the users, surgeons, and clinical specialists more efficient. The overall impact on the patients and healthcare is extensive and the technology is changing the way the surgical and diagnostics procedures are carried out today. From the diagnosis of a patient’s condition to the patient’s admittance to the actual surgery, and to the post operative treatment, the science that pervades the entire spectrum is dominated by sensors, hardware, embedded software, connected software, artificial intelligence and processing the information. The intent of this presentation is to provide an overview of the Advanced and Digital Surgery
    DeviceTalks Technical Forum
    Where
    Room 209

  • In this session we will delve into the practical implementation of the future of both robotic and digital surgery as delivered by the LUNA Surgical Platform. We will explore the development and introduction of cutting-edge technologies, sensing modalities, and the real-time data collection capabilities of the LUNA System. By harnessing these innovative technologies and investing in a multi-year development effort to cohesively integrate them, Asensus is poised to deliver on the promise of Performance Guided Surgery.
    DeviceTalks Technical Forum
    Where
    Room 207

  • Earlier this year, the FDA’s Center for Devices and Radiological Health (CDRH) launched the voluntary Total Product Life Cycle (TPLC) Advisory Program (TAP) Pilot. Start-up executives can hear from the program's leader about how the FDA is helping to clear the path for start-ups with innovative medical devices.
    DeviceTalks Technical Forum
    Where
    Room 210

  • Surgical robotics pioneer Intuitive is outpacing competitors in the industry by doubling down on its multi-port Da Vinci Robot while also introducing new robotics technologies to combat deadly diseases. In this interview, we'll hear how the company is building engineering and sales to teams to bring its systems to more hospitals in the US and abroad.
    Keynote
    Where
    Theater

  • The migration of procedures to outpatient and office-based settings will require surgical robotics companies to change how technology is designed, built and delivered. This panel will explore how this shift impacts usability, training, business models, distribution channels, and sales force construction.
    Keynote
    Where
    Theater

  • For children across the globe battling cardiovascular disease, some of the smallest solutions are having a huge impact. Find out the latest in pediatric medical innovation, including what goes into creating lifesaving heart devices for kids like Abbott’s Amplatzer Piccolo Occluder, HeartMate 3 heart pump, PediMag life support system and Masters HP 15mm mechanical heart valve. Also, hear what the future may hold in designing devices that help the tiniest patients live their best lives from the start.
    DeviceTalks
    Where
    Theater

  • With recent advances in artificial intelligence (AI), its potential to positively impact the medicine and help the patient is higher than ever. However, not all AI solutions are created equal, and it is important to build safe and effective AI solutions in a responsible manner. Join the session and learn how. We will overview the AI technology and then discuss strategy, best practices, and recent AI innovations from Medtronic.
    Bringing Devices to Market
    Where
    Room 210

  • Learn more about the latest innovation in therapies and technologies that are helping people that live with Parkinson’s or essential tremor. In a strategic collaboration, Boston Scientific and Brainlab joined forces to develop and deliver the latest advancements in deep brain stimulation that provides clinicians with real-time, 3-D visualization and stimulation of the brain anatomy.
    Engineering & Product Development
    Where
    Room 207

  • Moon Surgical are working non-stop to ready the company for commercialization. We'll hear from a few of their manufacturing team members on what it takes to get a new surgical robotics system into the market.
    Manufacturing & Materials
    Where
    Room 209

  • As NICO Corporation expanded their field organization to support their rapidly growing neurosurgery business, they needed technology and processes for enabling new and tenured reps. Hear how the team developed and executed a successful process for both onboarding reps and driving adoption of new software. Learn tips for building stronger relationships with sales reps, and why data is crucial for fostering better collaboration between leadership, sales operations, and the field.
    Manufacturing & Materials
    Where
    Room 209

  • Learn how medical device companies are using Infor’s Cloverleaf® Integration Suite software to streamline operations, accelerate innovation and find greater success. More than one-third of providers across North America (and an additional 800 in Europe) are using Cloverleaf to improve healthcare outcomes. This presents an enormous opportunity for medical device manufacturers eager to optimize patient and clinician workflows along with streamlining the supply chain. Attendees will be able to learn how interoperability between systems can increase productivity and encourage innovation.
    Bringing Devices to Market
    Where
    Room 210

  • Digital Design is not simply a build as you go Digital Twin for products, it is a digital signature of the product along inclusive of all design inputs, risk management, V&V planning, test cases and results. The Digital Design Input Library links relevant standards and regulations to the design and is reusable for future product iterations and new designs. Design Transfer becomes error-proof as all data elements are linked and transferred from specification to xBOMs and work instructions. Now your global supply chain and worldwide operations are enabled with one source of truth for the product. Digital Design challenges R&D, Quality, Operations and Regulatory teams to think beyond documents and envision the total product lifecycle as connected data. This is far more than a paperless approach. Digital Design pushes teams to leapfrog paperless to unleash the power of product data. In this session we will discuss the power and implications of Digital Design with industry, quality and software experts. We’ll explore questions such as: Is simulation accepted by regulators, notified bodies and your internal QA teams? Where can a company start on their Digital Design journey? What are the implications for Change Management? Can modeling and simulation be used to shift product testing earlier in the design and manufacturing planning processes? And more.
    Engineering & Product Development
    Where
    Room 207

  • In this panel we'll hear from corporate investors about how they view the cybersecurity risk and why they committed capital to this start-up.
    DeviceTalks
    Where
    Theater

  • Living with diabetes today looks very different than 5-10 years ago. For many, managing diabetes involved around-the-clock finger sticking and a constant worry to ensure glucose levels were within acceptable ranges. Today, advanced and digital technology can provide personalized information right in your hands to help you make decisions to live a healthy and fuller life. In this session, learn more about how new diabetes tech, such as FreeStyle Libre systems, has helped improve the lives of people living with diabetes, and how Abbott is designing future diabetes care tech such as a dual glucose-ketone sensor that could change how we look at diabetes care management.
    Engineering & Product Development
    Where
    Room 207

  • BD this year announced the commercial launch of a new automated instrument that prepares samples for clinical diagnostics using flow cytometry, enabling a complete "walkaway" workflow solution designed to improve standardization and reproducibility in cellular diagnostics. In this discussion, Steve Conly, worldwide president of BD Biosciences, will discuss the technology and detail the launch.
    Bringing Devices to Market
    Where
    Room 210

  • Medical device start-ups remain at the forefront of advancing interventional therapies. In this session, we'll hear from the leaders of three companies developing next generational tools for treating vascular and heart disease.
    Manufacturing & Materials
    Where
    Room 209

  • Development of surgical robotics involves more than software development. Often software development is limited by the hardware needed to execute the task. Viability of a surgical robotics platform requires both software and hardware to work in consort to deliver care. Relying on a contract manufacturer is an economical way to manufacture devices. Most contract manufacturers specialize in discreet areas, but commonly lack the holistic view to truly help innovative organizations. What is needed is a partner who is vertically integrated to incorporate innovation as well as manufacture a vision. Vertical integration including machining, sensor integration, assembly, and over-molding can help organizations realize their vision of bringing surgical robotics to the market.Come learn how Nissha Medical Technologies extensive experience in sensor integration and end effector development can help robotics organizations bring innovation to this emerging surgical modality.
    Bringing Devices to Market
    Where
    Room 210

  • We’re in an age of acceleration for healthcare and the pace of change to make surgery smarter, less invasive and more personalized is unprecedented. Rooted in Johnson & Johnson's heritage of solving the most critical unmet needs for patients and surgeons with market-defining innovation, Hani will discuss the next era of technological advancements in robotics, digital technology and connected ecosystems to make surgery better for everyone.
    Keynote
    Where
    Theater